Clinical Trial Details
EORTC-40085-75083
Back to Clinical Trials Database
Treatment of patients with KRAS and NRAS wild type advanced colorectal cancer with 5-fluorouracil (5-FU) or 5-FU plus an Epidermal Growth Factor Receptor inhibitor (cetuximab) based on a Comprehensive Geriatric Assessment
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 23-Apr-2013 Date Step1 close: 15-Jan-2015 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 5 - All Groups: 150 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT01522612 |
| NCT number | NCT01522612 |
| EudraCT | 2011-002947-83 |
